Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lode Wyns

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2002
All intermediates of the arsenate reductase mechanism, including an intramolecular dynamic disulfide cascadeJoris Messens, José C Martins, Karolien Van Belle, et al.
Plos One|May 1, 2008
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complexAdinda Wellens, Corinne Garofalo, Hien Nguyen, et al.
Journal of Molecular Biology|February 17, 2005
Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutationsMireille Dumoulin, Denis Canet, Alexander M Last, et al.
Journal of Medicinal Chemistry|January 31, 2014
Study of the structural and dynamic effects in the FimH adhesin upon α-d-heptyl mannose bindingSophie Vanwetswinkel, Alexander N Volkov, Yann G J Sterckx, et al.
Molecular Microbiology|August 26, 2006
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypesJulie Bouckaert, Jenny Mackenzie, José L de Paz, et al.
Nature|August 15, 2003
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozymeMireille Dumoulin, Alexander M Last, Aline Desmyter, et al.
The Journal of Physical Chemistry. B|August 8, 2013
A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formationErwin De Genst, Pak-Ho Chan, Els Pardon, et al.
Journal of Molecular Biology|April 6, 2013
Nanobodies raised against monomeric α-synuclein distinguish between fibrils at different maturation stagesTim Guilliams, Farah El-Turk, Alexander K Buell, et al.
Journal of Molecular Biology|July 13, 2010
Structure and properties of a complex of α-synuclein and a single-domain camelid antibodyErwin J De Genst, Tim Guilliams, Joke Wellens, et al.
Biochemistry|September 26, 2008
Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrilsPak-Ho Chan, Els Pardon, Linda Menzer, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2002
All intermediates of the arsenate reductase mechanism, including an intramolecular dynamic disulfide cascadeJoris Messens, José C Martins, Karolien Van Belle, et al.
Plos One|May 1, 2008
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complexAdinda Wellens, Corinne Garofalo, Hien Nguyen, et al.
Journal of Molecular Biology|February 17, 2005
Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutationsMireille Dumoulin, Denis Canet, Alexander M Last, et al.
Journal of Medicinal Chemistry|January 31, 2014
Study of the structural and dynamic effects in the FimH adhesin upon α-d-heptyl mannose bindingSophie Vanwetswinkel, Alexander N Volkov, Yann G J Sterckx, et al.
Molecular Microbiology|August 26, 2006
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypesJulie Bouckaert, Jenny Mackenzie, José L de Paz, et al.
Nature|August 15, 2003
A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozymeMireille Dumoulin, Alexander M Last, Aline Desmyter, et al.
The Journal of Physical Chemistry. B|August 8, 2013
A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formationErwin De Genst, Pak-Ho Chan, Els Pardon, et al.
Journal of Molecular Biology|April 6, 2013
Nanobodies raised against monomeric α-synuclein distinguish between fibrils at different maturation stagesTim Guilliams, Farah El-Turk, Alexander K Buell, et al.
Journal of Molecular Biology|July 13, 2010
Structure and properties of a complex of α-synuclein and a single-domain camelid antibodyErwin J De Genst, Tim Guilliams, Joke Wellens, et al.
Biochemistry|September 26, 2008
Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrilsPak-Ho Chan, Els Pardon, Linda Menzer, et al.
Pageof 9